- Home
- IMMX vs PNF Comparison
IMMX vs PNF Comparison
Compare IMMX & PNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMX
- PNF
- Stock Information
- Founded
- IMMX 2014
- PNF 2001
- Country
- IMMX United States
- PNF United States
- Employees
- IMMX N/A
- PNF N/A
- Industry
- IMMX Medicinal Chemicals and Botanical Products
- PNF Finance Companies
- Sector
- IMMX Health Care
- PNF Finance
- Exchange
- IMMX Nasdaq
- PNF Nasdaq
- Market Cap
- IMMX 50.1M
- PNF 59.6M
- IPO Year
- IMMX 2021
- PNF N/A
- Fundamental
- Price
- IMMX $1.75
- PNF $7.49
- Analyst Decision
- IMMX Strong Buy
- PNF
- Analyst Count
- IMMX 1
- PNF 0
- Target Price
- IMMX $7.00
- PNF N/A
- AVG Volume (30 Days)
- IMMX 47.5K
- PNF 29.1K
- Earning Date
- IMMX 05-08-2025
- PNF 01-01-0001
- Dividend Yield
- IMMX N/A
- PNF 5.17%
- EPS Growth
- IMMX N/A
- PNF N/A
- EPS
- IMMX N/A
- PNF N/A
- Revenue
- IMMX N/A
- PNF N/A
- Revenue This Year
- IMMX N/A
- PNF N/A
- Revenue Next Year
- IMMX N/A
- PNF N/A
- P/E Ratio
- IMMX N/A
- PNF N/A
- Revenue Growth
- IMMX N/A
- PNF N/A
- 52 Week Low
- IMMX $1.26
- PNF $6.37
- 52 Week High
- IMMX $3.13
- PNF $9.06
- Technical
- Relative Strength Index (RSI)
- IMMX 41.38
- PNF 39.49
- Support Level
- IMMX $1.64
- PNF $7.40
- Resistance Level
- IMMX $1.90
- PNF $7.76
- Average True Range (ATR)
- IMMX 0.14
- PNF 0.09
- MACD
- IMMX 0.00
- PNF -0.01
- Stochastic Oscillator
- IMMX 10.44
- PNF 25.00
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
About PNF PIMCO New York Municipal Income Fund
PIMCO New York Municipal Income Fund is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State and New York City income tax. The fund's portfolio of investments consists of investments in different sectors such as education, transportation, healthcare, and others.